Heidi Health是一家澳大利亚医疗AI公司，近期获得了由Point72 Private Investments领投的6500万美元B轮融资，公司投后估值达到4.65亿美元。该公司专注于开发AI医疗记录工具，并提供免费的核心AI医嘱记录产品，以及每月70美元的付费高级功能。Heidi Health的独特之处在于优先考虑医生采用，而非强制与电子健康记录系统集成。其目标是构建一个全能的AI临床助理，能够协助处理部分患者护理任务。此外，Heidi Health还计划推出AI医疗搜索功能，与OpenEvidence和Doximity等公司竞争，并承诺绝不通过制药广告盈利，以赢得医生的信任。该公司已在全球116个国家拥有用户，并计划利用此次融资加速在美国、英国和加拿大等地的扩张。

🌟 **AI医疗记录与助手:** Heidi Health是一家专注于AI医疗记录和助手的公司，其核心产品是免费的AI医嘱记录工具，并提供付费高级功能。公司旨在通过AI技术减轻医生的行政负担，并计划将其发展为能够协助处理部分患者护理任务的全能AI临床助理。

🚀 **融资与估值:** 公司近期完成了由Point72 Private Investments领投的6500万美元B轮融资，投后估值达到4.65亿美元。此次融资将用于扩展办公室地点、加速招聘，尤其是在美国、英国和加拿大等关键市场。

💡 **差异化竞争策略:** Heidi Health的核心优势在于其“开放式”策略，优先考虑医生的直接采用，而非强制与电子健康记录（EHR）系统深度集成。这种策略允许医生自由定制，并强调了AI工具的激活和采用率的重要性。

🌐 **全球化布局与未来愿景:** Heidi Health已在全球116个国家拥有医生用户，远超其北美地区主要竞争对手。公司未来计划推出AI医疗搜索功能，将与OpenEvidence和Doximity等公司展开竞争，并明确表示将坚守不通过制药广告盈利的原则，以建立医生信任。

Heidi Health just nabbed a $65 million Series B for its free AI medical scribe.It's competing with ambient tech from hot startups like Abridge and formidable incumbents like Epic.Heidi wants to build an AI medical search tool to compete with the likes of OpenEvidence.

The medical AI scribe space has been red-hot this year, with new unicorns emerging and incumbent giants digging in. Startup Heidi Health just raised fresh funding in a late bid to take them on.

The Australian healthcare AI company raised $65 million in a Series B round led by hedge fund manager Steve Cohen's Point72 Private Investments. The round values Heidi Health at $465 million post-money and brings its total funding to about $97 million to date.

The Series B raise comes just seven months after Heidi raised its $16.6 million Series A, led by Headline and including Anthology, Anthropic, and Menlo Ventures' $100 million partnership fund.

Heidi is gaining traction despite how crowded the ambient documentation space has become. It's competing against AI scribe startups like $5.3 billion Abridge and Ambience Healthcare, as well as behemoths like medical records company Epic, which said in August it would release its own AI clinical documentation product.

Cofounder and CEO Dr. Thomas Kelly, a former vascular surgery resident, founded Heidi Health in 2019 under the name Oscer with tech to help medical students study for their exams. Two years later, seeing a bigger opportunity to ease doctors' administrative burdens, he rebranded the company and pivoted toward automating clinical documentation.

One of Heidi's biggest differentiators, Kelly said, is prioritizing physician adoption over rigid integration with electronic health records.

Roughly half of Heidi's sales come from physicians signing up for its product directly, Kelly said, rather than through outpatient clinic or health system contracts. Heidi offers its core AI scribe product for free, with a $70-per-month premium tier that gives clinicians more personalized features like custom clinical note templates.

That "open plan" approach, as Kelly puts it, isn't popular with other AI scribe startups.

"For the startups that sell top-down, the open-plan structure can be scary because they're thinking about clinical documentation integrity and revenue cycle management, where you want some level of standardization. But the problem with AI tools is, you need activation and adoption," Kelly said. "You can have the best of the best worlds, where clinicians can still build what they like and get the utility, and then structure it as a secondary thing."

Heidi can afford to stray from standardization in part because its ultimate goal differs from that of its peers: The startup wants to build an all-in-one AI clinical assistant capable of handling some patient care tasks under a doctor's supervision. Alongside the Series B, Heidi launched a tool that calls patients on behalf of doctors to automate tasks like follow-up scheduling and reminders.

Other AI scribes are digging further into healthcare back-office workflows, a strategy that's gotten some companies into muddy waters as of late, like Abridge, which has relied heavily on its integration with shareholder-turned-competitor Epic.

"It's never been our value proposition to be the most integrated scribe with Epic, because we always thought that was the path to short-term sugar highs," Kelly said of AI scribe startups that prioritized EHR integration. "Yeah, you'll get lots of adoption, but then you'll probably just churn everyone and die when they replace you."

Heidi is also establishing a significant international presence, with physician users in 116 countries. Peers Abridge and Ambience have sold their tech exclusively in North America.

Kelly said the startup plans to use the Series B funding to help expand its office locations and accelerate hiring, especially in the US, UK, and Canada, while digging further into markets where clinicians have already picked up Heidi's product, like France, South Africa, Singapore, and Hong Kong.

Heidi Health's next bet will introduce a fresh set of formidable competitors. The startup wants to build AI medical search features in a bid that will pit Heidi against $3.5 billion startup OpenEvidence and public healthtech Doximity.

Kelly said Heidi is still considering whether to partner with another company or build the AI search engine itself. But he said the startup will draw some boundaries that companies like OpenEvidence and Doximity, which let pharmaceutical companies advertise to doctors on their platforms, have not.

"We will never monetize with pharma. I just think that's a red line, incompatible with being a tool that physicians can trust," he said.

Check out the 9-slide pitch deck Heidi Health used to raise $65 million for its AI scribe.